Charles M. Fernandez Featured in Outstanding Investor Digest About Fairholme Capital Management (Part Two)

Speaking with Outstanding Investor Digest in 2009, former Fairholme Capital Management President Charles M. Fernandez detailed his shareholder revenue–focused investment, acquisition, and restructuring approach. In particular, Charles M. Fernandez emphasized the need to undertake detailed research and analysis in every transaction undertaken.

The reason for this intense M&A scrutiny is that business acquisitions not only need to generate significant revenue to pay off debts, but also need to cover debt incurred during the acquisition process itself. Any major M&A process naturally requires extensive (and expensive) coordination with attorneys, regulators, lobbyists, and other stakeholders. In the pharmaceutical sector, Mr. Fernandez described a complex and time-consuming process of collaborating with leading Washington, D.C., lawyers experienced in lobbying Congress on behalf of the top pharmaceutical companies. He also typically hired consultants with detailed regulatory and law enforcement experience. These experts helped him to understand complex issues regarding government agency investigations, as well as relevant legal issues.

Charles M. Fernandez’s detail-oriented approach has paid dividends, with a sustained M&A strategy with Ivax Corporation over a seven-year period, transforming a small generics company into a major $10 billion international operation.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s